ArticleJournal of clinical medicine2025

Guts, Glucose, and Gallbladders: The Protective Role of GLP-1/GIP Receptor Agonists Against Biliary Complications in Patients with Type 2 Diabetes and Inflammatory Bowel Disease.

Muhammad Ali Ibrahim Kazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.